Please provide your email address to receive an email when new articles are posted on . Using an interventional approach to treat certain patients suffering from deep vein thrombosis may offer ...

When most of us think of a serious medical emergency, we usually think of sudden events such as heart attacks, strokes or serious injuries from a car crash. But some threats develop quietly, with ...

A NEW device for the treatment of deep vein thrombosis (DVT) has been found by an Irish researcher to be highly effective and much faster than the standard treatment. Dr Gerard O'Sullivan, an ...

The disadvantages of dabigatran include a higher cost compared with warfarin, the need for twice-daily dosing, and a slightly increased risk for gastrointestinal bleeding (6.1% with dabigatran vs 4% ...

O’Sullivan is an interventional radiologist — a physician who specializes in minimally invasive, targeted treatments. In mid-March at the Society of Interventional Radiology scientific meeting in ...

Deep Vein Thrombosis Companies in the treatment market are Bayer, LEO Pharma, Agen Biomedical, Bristol-Myers Squibb, Sanofi, Ottawa Hospital Research Institute, Daiichi Sankyo, MinaPharm ...

Deep vein thrombosis (DVT) is a blood clot (thrombus) in a deep vein, usually in the legs. These clots require medical care right away. These clots are dangerous because they can break loose, travel ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Deep vein thrombosis (DVT) is a condition that can affect anyone, but it gains attention during summer travel season because long ...

In their paper available on the medRxiv* preprint server, researchers from Russia showed that patients with moderate and severe coronavirus disease (COVID-19) have a high incidence of deep vein ...

Basilic vein thrombosis is a type of superficial venous thrombosis (SVT) in which a blood clot forms in the basilic vein in the arm. In many cases, SVT is harmless and will resolve without treatment.

Karlheinz Peter receives funding from the National Health & Medical Research Council (NHMRC), the Australian Research Council (ARC) and the National Heart Foundation (NHF). Ulrike Flierl does not work ...